Skip to main content
Fig. 5 | Journal of Ovarian Research

Fig. 5

From: Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys

Fig. 5

Effects of VEGFA neutralization during COS + SEP cycles. Serum progesterone (P4; a), ovarian blood volume (BV; b), and ovarian vascular rate of flow (VF; c), uterus VF (d), junction (basalis) VF (e), and endometrial VF (f) in control COS + SEP cycles and COS + SEP cycles + anti-VEGFA (Avastin) treatment. For details of treatments see Methods. Upper case letters indicate differences (P < 0.05) between COS + SEP and COS + SEP + Avastin treatment groups

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us